Collin Ewald
Comment
Stakeholder Type

Collin Ewald

Collin Ewald

Associate Director, Diseases of Aging and Regenerative MedicineNovartis Institutes for BioMedical Research
2025

Anticipation Committee member

Over 20 years in the aging research field (academia). Since 2023, Associate Director at Novartis Biomedical Research in Diseases of Aging and Regenerative Medicine.

Related Radar Content